GKOS Trading Analysis - 11/20/2026 05:05 PM โ€” TRU-SENTIMENT

GKOS (Glaukos Corporation) at $236.45. True Sentiment Bullish, delta 40-60 call 90% / put 10%, call $2,144,900 vs put $246,180. RSI 49.2.

TRU-SENTIMENT ยท DeltaNeutral

GKOS Trading Analysis - 11/20/2026 05:05 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

GKOS (Glaukos Corporation) at $236.45. True Sentiment Bullish, delta 40-60 call 90% / put 10%, call $2,144,900 vs put $246,180. RSI 49.2.

Symbol
GKOS
Price
$236.45
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-20 17:05:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only) shows Bullish conviction:

Call Dollar Volume: $2,144,900.00 (89.70%) Put Dollar Volume: $246,180.00 (10.30%) Total: $2,391,080.00

Call contracts 949 vs put contracts 76, with 14 call trades and 10 put trades. Pure directional positioning suggests strong near-term upside expectations. No divergence from technical uptrend; both sentiment and SMA alignment are bullish, though RSI neutral tempers conviction.

Note: Options flow shows heavy call buying at Delta 40-60 strikes, supporting continuation bias.

Key Statistics: GKOS

$237.31 +0.04%
52-Week Range
$93.78 - $255.19
Market Cap
$14.05B
P/E (TTM)
97.30
PEG Ratio
N/A
Beta
0.75
Next Earnings
N/A
Avg Volume
$699,513
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)97.30
EPS (trailing 12 mo)$-2.94
Market cap$14.05B
Shares outstanding59.2M

Dividend

Dividend yield0.00%

Risk & range

Beta0.75
52-week low$93.78
52-week high$255.19
Historical volatility97.4%

Ownership & trading

Institutional ownership88.0%
Average daily volume1.9M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following context items are based on general knowledge and are separated from the data-driven analysis below.

  • Glaukos (GKOS) reported third-quarter 2026 results in late October, with a surge in iDose implant adoption driving a sharp revenue beat and an unexpected jump in share price from the low $180s to near $240 on Oct 29.
  • Management raised full-year 2026 guidance during the Q3 call, citing expanded payer coverage for glaucoma surgical technologies as a key catalyst.
  • Recent sector news highlighted softening elective procedure volumes in early November, contributing to a pullback from the $255 30-day high to the $220โ€“240 range.
  • No confirmed near-term FDA panel date has been announced, but investors are monitoring potential supplemental approvals for next-gen glaucoma devices in Q1 2027.
  • Context: The Oct 29 gap-up and subsequent consolidation align with the embedded daily data showing a high of $255.19 and current price of $237.39.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for GKOS:

  • Trailing P/E is 97.30 and trailing EPS is -2.94, indicating the company is currently unprofitable on a trailing basis with a rich multiple relative to earnings (negative EPS).
  • PEG ratio, forward P/E, forward EPS, profit margins, revenue growth, ROE, and debt/equity are all null/unavailable in the data, preventing comparison to sector peers on those metrics.
  • Market cap is $14,048,040,070.00 with 59,197,000.00 shares outstanding and institutional ownership at 88.01%, reflecting strong institutional presence.
  • Dividend yield is 0.00% with no dividend declared; beta is 0.75 (less volatile than market).
  • 52-week range is $93.78 to $255.19; historical volatility is 97.41% and average volume is 1,912,000.00.
  • Analyst consensus and target price are null in the data, so no street target context is available.
  • Fundamentals (negative EPS, high trailing P/E) diverge from the bullish technical and options-sentiment picture, suggesting the rally is momentum/catalyst-driven rather than backed by current profitability.

Current Market Position

Current price per indicators is $237.39 (daily close 2026-11-20: $237.39). Recent daily action shows a peak of $255.19 on 2026-11-04, a drop to $220.31 on 2026-11-05, recovery to $247.90 on 2026-11-11, then consolidation between $232.68 and $246.46 through 2026-11-18, with Nov 19 close $237.21 and Nov 20 close $237.39.

Minute bars for 2026-11-19 to 2026-11-20 show opening around $234.80, intraday low $231.61 (Nov 19) and $233.40 (Nov 20), late-session volume spikes on 2026-11-20 15:50โ€“15:55 (46,617 then 92,731 shares) with close drifting to $236.45. Intraday momentum is choppy but stable near $236โ€“237 into the close.

Support (Daily Low Nov 20)
$233.40
Resistance (30d High)
$255.19
Recent Close
$237.39
Upper Bollinger
$274.15
Lower Bollinger
$186.09

Technical Analysis

Technical Indicators

RSI (14)
49.19
MACD
14.50 / Signal 11.60
50-day SMA
$191.20
20-day SMA
$230.12
5-day SMA
$239.28
ATR (14)
11.58

SMA alignment: 5-day ($239.28) > 20-day ($230.12) > 50-day ($191.20), all rising versus the 50-day base, confirming a multi-timeframe uptrend with price ($237.39) just below the 5-day line. RSI at 49.19 is neutral, no overbought/oversold extremes. MACD histogram is +2.90 (14.50 minus 11.60), bullish but modest. Bollinger Bands: middle $230.12, upper $274.15, lower $186.09; price sits near mid-band, no squeeze (bands wide). 30-day range high $255.19, low $162.97; current price is ~62% up the range, below the $255.19 high.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only) shows Bullish conviction:

Call Dollar Volume: $2,144,900.00 (89.70%) Put Dollar Volume: $246,180.00 (10.30%) Total: $2,391,080.00

Call contracts 949 vs put contracts 76, with 14 call trades and 10 put trades. Pure directional positioning suggests strong near-term upside expectations. No divergence from technical uptrend; both sentiment and SMA alignment are bullish, though RSI neutral tempers conviction.

Note: Options flow shows heavy call buying at Delta 40-60 strikes, supporting continuation bias.

Key Price Levels (Observational Only)

Support (SMA 20)
$230.12
Support (Nov 20 Low)
$233.40
Resistance (5-day SMA)
$239.28
Resistance (30d High)
$255.19
Upper Bollinger
$274.15

Interactive charts load with JavaScript. This text is the crawlable summary.